![](https://monteverdelaw.com/wp-content/uploads/case-logo/graphite-bio-inc.png)
Graphite Bio, Inc. (Nasdaq: GRPH), relating to its proposed merger with LENZ Therapeutics. Under the terms of the agreement, GRPH shareholders will own approximately 35% of the combined company.
Graphite Bio, Inc. (Nasdaq: GRPH), relating to its proposed merger with LENZ Therapeutics. Under the terms of the agreement, GRPH shareholders will own approximately 35% of the combined company.